12 Health Care Stocks Moving In Monday's Pre-Market Session

Loading...
Loading...

Gainers

  • Celldex Therapeutics CLDX stock increased by 30.1% to $33.8 during Monday's pre-market session. The company's market cap stands at $1.5 billion. As per the press release, Q3 earnings came out 2 days ago.
  • Sensei Biotherapeutics SNSE shares moved upwards by 21.15% to $0.84. The company's market cap stands at $22.2 million.
  • Baudax Bio BXRX shares rose 14.4% to $0.25. The company's market cap stands at $2.3 million.
  • CervoMed CRVO shares moved upwards by 14.17% to $12.48. The market value of their outstanding shares is at $70.8 million.
  • Repare Therapeutics RPTX stock increased by 13.38% to $4.32. The market value of their outstanding shares is at $181.8 million.
  • OptimizeRx OPRX shares rose 11.3% to $9.45. The market value of their outstanding shares is at $170.8 million. The company's, Q3 earnings came out today.

Losers

  • Cerus CERS shares fell 20.8% to $1.37 during Monday's pre-market session. The market value of their outstanding shares is at $248.2 million. As per the news, the Q3 earnings report came out 2 days ago.
  • MoonLake MLTX shares declined by 18.1% to $42.0. The company's market cap stands at $2.2 billion.
  • NexImmune NEXI shares decreased by 14.68% to $2.5. The company's market cap stands at $2.6 million.
  • Acurx Pharmaceuticals ACXP shares fell 10.67% to $2.93. The company's market cap stands at $38.1 million.
  • Altamira Therapeutics CYTO shares declined by 9.47% to $0.14. The company's market cap stands at $1.0 million.
  • Kazia Therapeutics KZIA shares declined by 9.28% to $0.43. The company's market cap stands at $10.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...